Fluralaner CAS 864731-61-3 CAS NO.864731-61-3

Shipping

Company information

Fluralaner is a veterinary drug used primarily as an ectoparasiticide. It is effective in controlling and preventing infestations of fleas and ticks in dogs and cats.

Key Points about Fluralaner:

1. Mechanism of Action: Fluralaner works by inhibiting the activity of certain neurotransmitter receptors (specifically, the GABA and glutamate-gated chloride channels) in parasites. This leads to the paralysis and death of fleas and ticks. The compound disrupts the normal nerve function in these parasites, which results in their elimination.

2. Formulation: Fluralaner is typically administered orally in the form of chewable tablets for dogs and cats. The medication is absorbed into the bloodstream and distributed throughout the body, where it provides systemic protection against parasites.

3. Duration of Action: One of the advantages of Fluralaner is its long-lasting effect. It provides protection against fleas and ticks for several weeks to months, depending on the product formulation and dosage. For example, a single dose of Fluralaner can offer protection for up to 12 weeks.

4. Brand Names: Fluralaner is marketed under various brand names, such as Bravecto®.

5. Safety and Efficacy: Clinical studies and real-world use have demonstrated that Fluralaner is effective in managing flea and tick infestations. It is generally well-tolerated by pets, though like all medications, it may have potential side effects. Common side effects, if any, are usually mild and can include digestive upset or lethargy.

6. Approval: Fluralaner has been approved by veterinary regulatory agencies in various countries for use in treating and preventing flea and tick infestations in pets.

Overall, Fluralaner represents an important tool in veterinary medicine for managing ectoparasite infestations, offering convenience and extended protection for pets.